- Advertisement -spot_img
Wednesday, March 29, 2023

FDA Asks Court For 55 Years To Release Full Data On Pfizer’s COVID-19 Vaccine

The Food and Drug Administration (FDA) on November 15 asked a federal judge to grant him a deadline until 2076 to fully publish the documents in his possession related to the approval of the Pfizer-BioNTech COVID-19 vaccine.

The FDA request was made as part of a Freedom of Information Act (FOIA) lawsuit by a medical transparency group. The government told the court that it has 329,000 pages of documents responding to the FOIA’s request and has offered to produce 500 pages per month to edit the released material. At this rate, the FDA will fully release those records in just under 55 years.

The Plaintiff, Public Health and Medical Professionals for Transparency (PHMPT), is a group of doctors and scientists, including Harvey Risch, professor of epidemiology at the Yale School of Public Health.

The group filed a lawsuit (pdf) after the FDA denied their request to expedite the release of the records. Plaintiff and defendant, unable to agree on a disclosure schedule, seek a hearing to discuss their cases before a judge who may ultimately decide on the matter.

“The FDA’s promise of transparency is, to put it mildly, a bunch of illusions,” wrote Aaron Siri, whose firm is representing PHMPT in the lawsuit, on a November 17 blog.

“It was exactly 108 days for the FDA from the time Pfizer started releasing the licensing records to the time the FDA licensed the Pfizer vaccine,” Siri continued. “Taking the FDA’s word for it, it has conducted an intensive, reliable, thorough and complete review and analysis of these documents to ensure that Pfizer’s vaccine is safe and effective for licensing. While he can do a thorough review of Pfizer documents in 108 days, it now takes more than 20,000 days to make those documents publicly available. ”

The FDA did not respond to a request for comment.

The FDA licensed the Comirnaty-branded Pfizer COVID-19 vaccine on August 23, 2021, less than four months after Pfizer began filing for full approval of the drug. The FDA license approval in late August led to an avalanche of vaccine demands in the private and public sectors.

COVID-19 is a disease caused by the CCP (Chinese Communist Party) virus, commonly known as the novel coronavirus.

One of the companies involved in Pfizer’s vaccine trials earlier this month said it was investigating alleged problems identified by a whistleblower, who told the British Medical Journal (BMJ) that the trial was riddled with problems, including data falsification.

The informant, Brooke Jackson, notified the FDA and was fired within hours. In the fall of 2020, Jackson worked for the Ventavia Research Group, which operated several Pfizer test sites.

According to BMJ, one of the oldest medical journals in the world, the FDA has not reviewed the Ventavia trial sites despite being warned of problems.

The FDA told The Epoch Times in an email earlier this month that while it is unable to comment on the Ventavia issue, it “has full confidence in the data used to validate the Pfizer-BioNTech COVID-19 vaccine and Comirnaty’s approval. … “

As of November 14, over 256 million doses of Pfizer’s COVID-19 vaccine have been administered in the United States.

Zachary Stieber contributed to this report.

To follow

Ivan has been writing for The Epoch Times on a variety of topics since 2011.

World Nation News Desk
World Nation News Deskhttps://worldnationnews.com/
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -


Please enter your comment!
Please enter your name here